Skip to main content

Table 4 Hospital course of the studied VA-ECMO-treated patients

From: Acute vascular complications of femoral veno-arterial ECMO: a single-centre retrospective study

Studied criteria

All patients

Limb ischemia group

No limb ischemia group

P value

Acute Kidney injury

39 (60)

21 (100)

18 (40.9)

< 0.001

Renal replacement therapy

27 (41.5)

12 (57.1)

15 (34.1)

0.07

Cerebrovascular stroke

13 (20)

5 (23.8)

8 (18.2)

0.74

Cerebral ischemic stroke

7 (11.9)

3 (17.6)

4 (9.5)

0.39

Intracerebral haemorrhage

6 (10.2)

2 (11.8)

4 (9.5)

0.9

ICU days

19 (3–191)

19 (10–93)

17 (3–191)

0.028

Ventilator days

10 (2–191)

14 (5–81)

9 (2–191)

0.053

Gastrointestinal bleeding

14 (21.5)

4 (19)

10 (22.7)

0.92

Atrial fibrillation

25 (38.5)

9 (42.9)

16 (36.4)

0.61

Intracardiac thrombi

4 (6.2)

1 (4.8)

3 (6.8)

0.9

ECMO circuits thrombi

4 (6.2)

1 (4.8)

3 (6.8)

0.9

ECMO days before ischemia

6 (1–21)

6 (1–21)

-------

----

ECMO days

8 (3–40)

7 (4–40)

8 (3–32)

0.27

Changing to central VA-ECMO

3 (4.6)

2 (9.5)

1 (2.3)

0.29

Changing to LVAD

11 (16.9)

4 (19)

7 (15.9)

0.34

Decannulation and no MCS

51 (78.5)

15 (71.4)

36 (81.8)

0.41

Hospital mortality

29 (44.6)

9 (42.9)

20 (45.5)

0.84

SOFA score day 1

12 (8–21)

10 (8–21)

14 (8–21)

0.008

SOFA score day 3

13 (6–24)

10 (7–22)

14 (6–24)

0.034

∆ 1 SOFA

− 1 (− 5 to 6)

1 (− 4 to 6)

− 2 (− 5 to 6)

0.12

SOFA score day 5

10 (5–24)

9 (6–21)

10 (5–24)

0.45

∆ 2 SOFA

− 2 (− 7 to 9)

0 (− 5 to 8)

− 3 (− 7 to 9)

0.14

  1. Data are presented as number (%) or median (IQR)